These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9075682)

  • 1. Subfulminant syncytial giant cell hepatitis: recurrence after liver transplantation treated with ribavirin.
    Durand F; Degott C; Sauvanet A; Molas G; Sicot C; Marcellin P; Belghiti J; Erlinger S; Benhamou JP; Bernuau J
    J Hepatol; 1997 Mar; 26(3):722-6. PubMed ID: 9075682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of giant cell hepatitis recurring after liver transplantation and treated with ribavirin.
    Hassoun Z; N'Guyen B; Cote J; Marleau D; Willems B; Roy A; Dagenais M; Lapointe R; Letourneau R; Villeneuve JP
    Can J Gastroenterol; 2000 Sep; 14(8):729-31. PubMed ID: 11185540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent giant cell hepatitis in an 18 year old liver transplant patient.
    Shah JA; Steinbrecher UP; Erb SR; Tha SP; Yoshida EM
    Ann Hepatol; 2008; 7(3):257. PubMed ID: 18753995
    [No Abstract]   [Full Text] [Related]  

  • 4. Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature.
    Moreno A; Moreno A; Pérez-Elías MJ; Quereda C; Fernández-Muñoz R; Antela A; Moreno L; Bárcena R; López-San Román A; Celma ML; García-Martos M; Moreno S
    Hum Pathol; 2006 Oct; 37(10):1344-9. PubMed ID: 16949926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute lobular hepatitis as the first manifestation of recurrent autoimmune hepatitis after orthotopic liver transplantation.
    Sempoux C; Horsmans Y; Lerut J; Rahier J; Geubel A
    Liver; 1997 Dec; 17(6):311-5. PubMed ID: 9455738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syncytial giant-cell hepatitis due to autoimmune hepatitis type II (LKM1+) presenting as subfulminant hepatitis.
    Ben-Ari Z; Broida E; Monselise Y; Kazatsker A; Baruch J; Pappo O; Skappa E; Tur-Kaspa R
    Am J Gastroenterol; 2000 Mar; 95(3):799-801. PubMed ID: 10710079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon Alfa-2A and ribavirin therapy for hepatitis C recurrence after liver transplantation.
    Wietzke P; Braun F; Ringe B; Ramadori G
    Transplant Proc; 2000 Nov; 32(7):2539-42. PubMed ID: 11120284
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrosing cholestatic hepatitis after successful interferon and ribavirin therapy for recurrent hepatitis C post living related liver transplantation: a case report.
    Yamamoto T; Tanaka S; Uenishi T; Kanazawa A; Kubo S; Hirohashi K
    Osaka City Med J; 2014 Dec; 60(2):95-100. PubMed ID: 25803885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent hepatitis C after liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy.
    Hanouneh IA; Miller C; Aucejo F; Lopez R; Quinn MK; Zein NN
    Liver Transpl; 2008 Jan; 14(1):53-8. PubMed ID: 18161839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syncytial giant cell hepatitis in a patient with chronic lymphocytic leukemia.
    Gupta N; Njei B
    J Dig Dis; 2015 Nov; 16(11):683-8. PubMed ID: 26147671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nursing Problems in Care of a Patient with Very Early HCV Infection Recurrence After Liver Transplantation: A Case Report.
    Hreńczuk M; Sowińska R; Tronina O; Małkowski P; Durlik M; Pacholczyk M; Kosieradzki M
    Ann Transplant; 2016 Jun; 21():400-7. PubMed ID: 27357745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent postinfantile syncytial giant cell hepatitis after orthotopic liver transplantation.
    Lerut JP; Claeys N; Ciccarelli O; Pisa R; Galant C; Laterre PF; Palazzo U
    Transpl Int; 1998; 11(4):320-2. PubMed ID: 9704401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for fulminant genotype 2a/c hepatitis C virus marked by a rapid recurrence followed by cure.
    Tracy B; Shrestha R; Stein L; Bhasin D; Pollinger H; Rubin RA
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitiligo improvement in a hepatitis C patient after treatment with PEG-interferon alpha-2a and ribavirin: a case report.
    Taffaro M; Pyrsopoulos N; Cedron H; Cacayorin E; Weppler D; Moon J; Nishida S; Levi D; Kato T; Selvaggi G; Tzakis A; Schiff E
    Dig Dis Sci; 2007 Dec; 52(12):3435-7. PubMed ID: 17431776
    [No Abstract]   [Full Text] [Related]  

  • 15. HHV-6A in syncytial giant-cell hepatitis.
    Potenza L; Luppi M; Barozzi P; Rossi G; Cocchi S; Codeluppi M; Pecorari M; Masetti M; Di Benedetto F; Gennari W; Portolani M; Gerunda GE; Lazzarotto T; Landini MP; Schulz TF; Torelli G; Guaraldi G
    N Engl J Med; 2008 Aug; 359(6):593-602. PubMed ID: 18687640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
    Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
    Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.
    Carrión JA; Navasa M; García-Retortillo M; García-Pagan JC; Crespo G; Bruguera M; Bosch J; Forns X
    Gastroenterology; 2007 May; 132(5):1746-56. PubMed ID: 17484872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
    Charlton M; Gane E; Manns MP; Brown RS; Curry MP; Kwo PY; Fontana RJ; Gilroy R; Teperman L; Muir AJ; McHutchison JG; Symonds WT; Brainard D; Kirby B; Dvory-Sobol H; Denning J; Arterburn S; Samuel D; Forns X; Terrault NA
    Gastroenterology; 2015 Jan; 148(1):108-17. PubMed ID: 25304641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hepatitis B in a patient with OLT during treatment with peg-interferon and ribavirin for hepatitis C recurrence.
    Biliotti E; Zacharia S; Grieco S; Spaziante M; Giusto M; Merli M; Gallinaro V; Taliani G
    J Chemother; 2012 Dec; 24(6):369-72. PubMed ID: 23174103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect and safety of the treatment of recurrent hepatitis C infection after orthotopic liver transplantation with pegylated interferon α2b and ribavirin.
    Perrakis A; Yedibela S; Schuhmann S; Croner R; Schellerer V; Demir R; Hohenberger W; Müller V
    Transplant Proc; 2011 Dec; 43(10):3824-8. PubMed ID: 22172854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.